Deirdre Connelly
Chairman at GENMAB A/S
Net worth: 2 M $ as of 2024-11-29
Profile
Presently, Deirdre P. Connelly is Chairman for Genmab A. She is also on the board of Macy's, Inc. and Lincoln National Corp. and Director-Public Health Policy Council at Harvard University. Ms. Connelly previously held the position of President-US Operations at Eli Lilly & Co. and General Manager-Sales at Eli Lilly Export S.A. (a subsidiary of Eli Lilly & Co.), President-North American Pharmaceuticals at GlaxoSmithKline Plc President & Chief Executive Officer for Human Genome Sciences, Inc. and President-North America Pharmaceuticals at Genelabs Technologies, Inc. (both are subsidiaries of GlaxoSmithKline Plc) and Executive Director-Global Marketing at Evista Industries, Inc. Ms. Connelly received an undergraduate degree from Lycoming College.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
GENMAB A/S
0.01% | 2024-02-13 | 5,750 ( 0.01% ) | 1 M $ | 2024-11-29 |
2024-09-11 | 2,842 ( 0.00% ) | 378 952 $ | 2024-11-29 | |
MACY'S, INC.
0.00% | 2024-05-16 | 10,842 ( 0.00% ) | 176 074 $ | 2024-11-29 |
LINCOLN NATIONAL CORP
0.00% | 2024-09-29 | 4,000 ( 0.00% ) | 142 160 $ | 2024-11-29 |
Latest news about Deirdre Connelly
Deirdre Connelly active positions
Companies | Position | Start |
---|---|---|
MACY'S, INC. | Director/Board Member | 2007-12-31 |
LINCOLN NATIONAL CORPORATION | Director/Board Member | 2016-05-25 |
GENMAB A/S | Chairman | 2020-03-25 |
SAREPTA THERAPEUTICS, INC. | Director/Board Member | 2024-09-11 |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Former positions of Deirdre Connelly
Companies | Position | End |
---|---|---|
GSK PLC | Corporate Officer/Principal | 2015-01-31 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Chief Executive Officer | 2015-01-31 |
Genelabs Technologies, Inc.
Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Corporate Officer/Principal | 2014-12-31 |
ELI LILLY AND COMPANY | Human Resources Officer | 2005-05-31 |
░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Deirdre Connelly
Lycoming College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 6 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
MACY'S, INC. | Retail Trade |
GSK PLC | Health Technology |
LINCOLN NATIONAL CORPORATION | Finance |
GENMAB A/S | Health Technology |
SAREPTA THERAPEUTICS, INC. | Health Technology |
Private companies | 6 |
---|---|
Eli Lilly Export SA | |
Genelabs Technologies, Inc.
Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Health Technology |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Evista Industries, Inc.
Evista Industries, Inc. Miscellaneous Commercial ServicesCommercial Services Evista Industries, Inc. provides environmental consulting services to the property insurance and restoration industry. It offers full survey, renovation survey, project design, project management, monitoring and clearance assessment services. The company was founded by Joseph Anthony Wright in 2005 and is headquartered in Newport Beach, CA. | Commercial Services |
Norwest Indiana, Inc. | Finance |
- Stock Market
- Insiders
- Deirdre Connelly